Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours

Abstract

Analysis of molecular aberrations across multiple cancer types, known as pan-cancer analysis, identifies commonalities and differences in key biological processes that are dysregulated in cancer cells from diverse lineages. Pan-cancer analyses have been performed for adult 1,2,3,4 but not paediatric cancers, which commonly occur in developing mesodermic rather than adult epithelial tissues 5 . Here we present a pan-cancer study of somatic alterations, including single nucleotide variants, small insertions or deletions, structural variations, copy number alterations, gene fusions and internal tandem duplications in 1,699 paediatric leukaemias and solid tumours across six histotypes, with whole-genome, whole-exome and transcriptome sequencing data processed under a uniform analytical framework. We report 142 driver genes in paediatric cancers, of which only 45% match those found in adult pan-cancer studies; copy number alterations and structural variants constituted the majority (62%) of events. Eleven genome-wide mutational signatures were identified, including one attributed to ultraviolet-light exposure in eight aneuploid leukaemias. Transcription of the mutant allele was detectable for 34% of protein-coding mutations, and 20% exhibited allele-specific expression. These data provide a comprehensive genomic architecture for paediatric cancers and emphasize the need for paediatric cancer-specific development of precision therapies.

Cited by papers we hold 19

• Insights for precision oncology from the integration of genomic and clinical data of 13,880 tumors from the 100,000 Genomes Cancer Programme · 2024
  No notice
• Pan-cancer analysis of oncogenic role of Programmed Cell Death 2 Like (PDCD2L) and validation in colorectal cancer · 2022
  Not checked
• Unraveling the Genetic Architecture of Hepatoblastoma Risk: Birth Defects and Increased Burden of Germline Damaging Variants in Gastrointestinal/Renal Cancer Predisposition and DNA Repair Genes · 2022
  Not checked
• TP53 and TP53-associated genes are correlated with the prognosis of paediatric neuroblastoma · 2022
  Not checked
• MutationalPatterns: the one stop shop for the analysis of mutational processes · 2022
  No notice
• Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden · 2021
  No notice
• Immuno-genomic landscape of osteosarcoma · 2020
  No notice
• An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity · 2020
  No notice
• Multi-omics Data Integration, Interpretation, and Its Application · 2020
  No notice
• Molecular profiling for precision cancer therapies · 2020
  No notice
• Pan-neuroblastoma analysis reveals age- and signature-associated driver alterations · 2020
  No notice
• Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing · 2020
  Corrected
• Dangerous liaisons: interplay between SWI/SNF, NuRD, and Polycomb in chromatin regulation and cancer · 2019
  No notice
• Analysis of error profiles in deep next-generation sequencing data · 2019
  No notice
• Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design · 2019
  No notice
• Pan-cancer whole-genome analyses of metastatic solid tumours · 2019
  No notice
• Acute depletion of CTCF directly affects MYC regulation through loss of enhancer–promoter looping · 2019
  No notice
• Deep Learning-Based Multi-Omics Data Integration Reveals Two Prognostic Subtypes in High-Risk Neuroblastoma · 2018
  No notice
• Multi-omic tumor data reveal diversity of molecular mechanisms that correlate with survival · 2018
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.